Eculizumab in treatment for complement-mediated thrombotic microangiopathy associated with acute pancreatitis

Authors

  • Shruti Shettigar Division of Nephrology, Hypertension, and Renal Transplantation, University of Florida - College of Medicine, Gainesville, Florida, USA https://orcid.org/0009-0004-0842-450X
  • Rutvikkumar Jadvani Division of Nephrology, Hypertension, and Renal Transplantation, University of Florida - College of Medicine, Gainesville, Florida, USA https://orcid.org/0009-0000-3926-7288
  • Dwij Doshi Rahul International School, Mira Road, Thane, Maharashtra, India https://orcid.org/0009-0009-1639-7130
  • Chintan V. Shah Division of Nephrology, Hypertension, and Renal Transplantation, University of Florida - College of Medicine, 1600 SW Archer Road, Room CG-98, Gainesville, FL 32610, Office: (352) 294-8790. E-mail: shahc@ufl.edu https://orcid.org/0000-0002-4097-4606

DOI:

https://doi.org/10.17179/excli2025-8881

Keywords:

Eculizumab, acute pancreatitis, thrombotic microangiopathy (TMA)

Published

2025-12-18

How to Cite

Shettigar, S., Jadvani, R., Doshi, D., & Shah, C. V. (2025). Eculizumab in treatment for complement-mediated thrombotic microangiopathy associated with acute pancreatitis. EXCLI Journal, 24, 1802–1803. https://doi.org/10.17179/excli2025-8881

Issue

Section

Letters to the editor

Categories

Most read articles by the same author(s)